News

China Pharma (CPHI) Stock: Why It Has Been Volatile This Week

The stock price of China Pharma (CPHI) has been volatile this week. This is why.

12/06/2022

3 Penny Stocks, Are They Worth Buying Right Now?

Check these three penny stocks out for your watchlist right now The post 3 Penny Stocks, Are They Worth Buying Right Now? appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

06/09/2022

Profitability

Dividends

Income Statement

Balance Sheet

Cash Flow Statement

Symbol Frequently Asked Questions

Is China Pharma Holdings, Inc. (CPHI) a buy, sell, or hold?

China Pharma Holdings, Inc. (CPHI) can sell. Click on Rating Page for detail.

What is China Pharma Holdings, Inc.'s stock price?

The price of China Pharma Holdings, Inc. (CPHI) is 0.3183 and it was updated on 2024-05-05 07:00:47.

Is China Pharma Holdings, Inc. (CPHI) overvalued or undervalued?

Currently China Pharma Holdings, Inc. (CPHI) is in undervalued.

News

From:

To:

News
7 Discord Stocks Investors Are Pumping Higher Move over Reddit! These popular Discord stocks just might give fans of speculative opportunities the swing trades they're looking for. Mon, Aug. 23, 2021
China Pharma Holdings, Inc. Reports Second Quarter 2021 Financial Results HAIKOU, China, Aug. 13, 2021 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based in China, today announced the financial results for the quarter ended June 30, 2021. Revenue decreased by 35.9% to $2.4 million for the three months ended June 30, 2021, as compared to $3.8 million for the three months ended June 30, 2020. Fri, Aug. 13, 2021
China Pharma's Candesartan Hypertension Product Passes Bioequivalence Tests and the Company Plans to Apply for NMPA Approval HAIKOU, China , Aug. 5, 2021 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), a specialty pharmaceutical company, today announced that its Candesartan hypertension product passed key bioequivalence tests. The Company plans to use the results of the key benchmark tests of consistency evaluation to apply for the National Medical Products Administration's (NMPA) approval. Thu, Aug. 05, 2021
China Pharma to Launch Highly Purified NMN+PQQ Product HAIKOU, China, June 9, 2021 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), a specialty pharmaceutical company, today announced plans to launch a highly purified NMN+PQQ product following the recent successful completion of a pilot scale test. β-Nicotinamide mononucleotide (NMN) is a derivative of the B-vitamin niacin, which is believed to significantly improve health and wellness. Wed, Jun. 09, 2021
China Pharma Holdings, Inc. Reports 33% YoY Increase in First Quarter 2021 Revenue HAIKOU, China, May 14, 2021 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), a specialty pharmaceutical company, today announced financial results for the quarter ended March 31, 2021. Revenue increased by 33.7% to $2.4 million for the three months ended March 31, 2021, as compared to $1.8 million for the three months ended March 31, 2020. Fri, May. 14, 2021

SEC Filings

SEC Filings
China Pharma Holdings, Inc. (CPHI) - 10-K - Current report SEC Filings 04/01/2024
China Pharma Holdings, Inc. (CPHI) - 8-K - Current report SEC Filings 03/29/2024
China Pharma Holdings, Inc. (CPHI) - 8-K - Current report SEC Filings 02/23/2024
China Pharma Holdings, Inc. (CPHI) - EFFECT SEC Filings 02/15/2024
China Pharma Holdings, Inc. (CPHI) - 8-K - Current report SEC Filings 02/08/2024
China Pharma Holdings, Inc. (CPHI) - S-3/A SEC Filings 02/06/2024
China Pharma Holdings, Inc. (CPHI) - SC 13G SEC Filings 01/26/2024
China Pharma Holdings, Inc. (CPHI) - 3 SEC Filings 01/26/2024
China Pharma Holdings, Inc. (CPHI) - SC 13G/A SEC Filings 01/12/2024
China Pharma Holdings, Inc. (CPHI) - S-3 SEC Filings 01/12/2024
China Pharma Holdings, Inc. (CPHI) - 8-K - Current report SEC Filings 12/21/2023
China Pharma Holdings, Inc. (CPHI) - 8-K - Current report SEC Filings 12/19/2023
China Pharma Holdings, Inc. (CPHI) - 10-Q - Quarterly Report SEC Filings 11/13/2023
China Pharma Holdings, Inc. (CPHI) - DEF 14A SEC Filings 11/07/2023
China Pharma Holdings, Inc. (CPHI) - PRE 14A SEC Filings 10/27/2023
China Pharma Holdings, Inc. (CPHI) - 4 SEC Filings 10/19/2023
China Pharma Holdings, Inc. (CPHI) - 8-K - Current report SEC Filings 10/03/2023
China Pharma Holdings, Inc. (CPHI) - 10-Q - Quarterly Report SEC Filings 08/14/2023
China Pharma Holdings, Inc. (CPHI) - 10-Q - Quarterly Report SEC Filings 05/12/2023
China Pharma Holdings, Inc. (CPHI) - 8-K - Current report SEC Filings 04/20/2023
China Pharma Holdings, Inc. (CPHI) - 10-K - Current report SEC Filings 03/30/2023
China Pharma Holdings, Inc. (CPHI) - 8-K - Current report SEC Filings 03/29/2023
China Pharma Holdings, Inc. (CPHI) - SC 13G SEC Filings 03/09/2023
China Pharma Holdings, Inc. (CPHI) - 3 SEC Filings 03/09/2023
China Pharma Holdings, Inc. (CPHI) - 8-K - Current report SEC Filings 02/24/2023
China Pharma Holdings, Inc. (CPHI) - 8-K - Current report SEC Filings 12/30/2022
China Pharma Holdings, Inc. (CPHI) - SC 13G/A SEC Filings 12/05/2022
China Pharma Holdings, Inc. (CPHI) - 8-K - Current report SEC Filings 12/02/2022
China Pharma Holdings, Inc. (CPHI) - DEF 14A SEC Filings 11/14/2022
China Pharma Holdings, Inc. (CPHI) - 10-Q - Quarterly Report SEC Filings 11/14/2022
China Pharma Holdings, Inc. (CPHI) - PRE 14A SEC Filings 11/04/2022
China Pharma Holdings, Inc. (CPHI) - S-8 SEC Filings 10/24/2022
China Pharma Holdings, Inc. (CPHI) - 8-K - Current report SEC Filings 09/30/2022
China Pharma Holdings, Inc. (CPHI) - SC 13G SEC Filings 09/27/2022
China Pharma Holdings, Inc. (CPHI) - 10-Q - Quarterly Report SEC Filings 08/11/2022
China Pharma Holdings, Inc. (CPHI) - 8-K - Current report SEC Filings 06/22/2022
China Pharma Holdings, Inc. (CPHI) - 10-Q - Quarterly Report SEC Filings 05/12/2022
China Pharma Holdings, Inc. (CPHI) - 10-K - Current report SEC Filings 03/30/2022
China Pharma Holdings, Inc. (CPHI) - 8-K - Current report SEC Filings 12/29/2021
China Pharma Holdings, Inc. (CPHI) - 424B5 SEC Filings 12/16/2021
China Pharma Holdings, Inc. (CPHI) - D SEC Filings 11/29/2021
China Pharma Holdings, Inc. (CPHI) - 8-K - Current report SEC Filings 11/23/2021
China Pharma Holdings, Inc. (CPHI) - DEFA14A SEC Filings 11/15/2021
China Pharma Holdings, Inc. (CPHI) - DEF 14A SEC Filings 11/15/2021
China Pharma Holdings, Inc. (CPHI) - 10-Q - Quarterly Report SEC Filings 11/12/2021
China Pharma Holdings, Inc. (CPHI) - 8-K - Current report SEC Filings 09/15/2021
China Pharma Holdings, Inc. (CPHI) - 4 SEC Filings 09/13/2021
China Pharma Holdings, Inc. (CPHI) - 10-Q - Quarterly Report SEC Filings 08/13/2021
China Pharma Holdings, Inc. (CPHI) - 10-Q - Quarterly Report SEC Filings 05/14/2021
China Pharma Holdings, Inc. (CPHI) - 10-K - Current report SEC Filings 03/26/2021
China Pharma Holdings, Inc. (CPHI) - EFFECT SEC Filings 01/22/2021
China Pharma Holdings, Inc. (CPHI) - EFFECT SEC Filings 01/21/2021
China Pharma Holdings, Inc. (CPHI) - CORRESP SEC Filings 01/19/2021
China Pharma Holdings, Inc. (CPHI) - UPLOAD SEC Filings 01/15/2021
China Pharma Holdings, Inc. (CPHI) - S-3 SEC Filings 01/08/2021
China Pharma Holdings, Inc. (CPHI) - 4 SEC Filings 01/08/2021
China Pharma Holdings, Inc. (CPHI) - 8-K - Current report SEC Filings 12/29/2020
China Pharma Holdings, Inc. (CPHI) - S-8 SEC Filings 12/21/2020
China Pharma Holdings, Inc. (CPHI) - DEFA14A SEC Filings 11/16/2020
China Pharma Holdings, Inc. (CPHI) - DEF 14A SEC Filings 11/16/2020
China Pharma Holdings, Inc. (CPHI) - 10-Q - Quarterly Report SEC Filings 11/13/2020
China Pharma Holdings, Inc. (CPHI) - 10-Q - Quarterly Report SEC Filings 08/13/2020
China Pharma Holdings, Inc. (CPHI) - 10-Q - Quarterly Report SEC Filings 05/14/2020
China Pharma Holdings, Inc. (CPHI) - 10-K - Current report SEC Filings 03/30/2020
China Pharma Holdings, Inc. (CPHI) - 8-K - Current report SEC Filings 12/23/2019
China Pharma Holdings, Inc. (CPHI) - 10-Q - Quarterly Report SEC Filings 11/14/2019
China Pharma Holdings, Inc. (CPHI) - DEFA14A SEC Filings 11/06/2019
China Pharma Holdings, Inc. (CPHI) - DEF 14A SEC Filings 11/06/2019
China Pharma Holdings, Inc. (CPHI) - 10-Q - Quarterly Report SEC Filings 08/14/2019
China Pharma Holdings, Inc. (CPHI) - 10-Q - Quarterly Report SEC Filings 05/14/2019
China Pharma Holdings, Inc. (CPHI) - 10-K - Current report SEC Filings 03/28/2019
China Pharma Holdings, Inc. (CPHI) - 8-K - Current report SEC Filings 12/06/2018
China Pharma Holdings, Inc. (CPHI) - 10-Q - Quarterly Report SEC Filings 11/14/2018
China Pharma Holdings, Inc. (CPHI) - DEFA14A SEC Filings 10/25/2018
China Pharma Holdings, Inc. (CPHI) - DEF 14A SEC Filings 10/25/2018
China Pharma Holdings, Inc. (CPHI) - 10-Q - Quarterly Report SEC Filings 08/14/2018
China Pharma Holdings, Inc. (CPHI) - 10-Q - Quarterly Report SEC Filings 05/14/2018
China Pharma Holdings, Inc. (CPHI) - 10-K - Current report SEC Filings 04/02/2018
China Pharma Holdings, Inc. (CPHI) - 8-K - Current report SEC Filings 03/12/2018
China Pharma Holdings, Inc. (CPHI) - 8-K - Current report SEC Filings 12/18/2017
China Pharma Holdings, Inc. (CPHI) - 10-Q - Quarterly Report SEC Filings 11/14/2017
China Pharma Holdings, Inc. (CPHI) - DEFA14A SEC Filings 11/03/2017
China Pharma Holdings, Inc. (CPHI) - DEF 14A SEC Filings 11/03/2017
China Pharma Holdings, Inc. (CPHI) - 8-K - Current report SEC Filings 09/12/2017
China Pharma Holdings, Inc. (CPHI) - 10-Q - Quarterly Report SEC Filings 08/14/2017
China Pharma Holdings, Inc. (CPHI) - 10-Q - Quarterly Report SEC Filings 05/11/2017
China Pharma Holdings, Inc. (CPHI) - 8-K - Current report SEC Filings 03/31/2017
China Pharma Holdings, Inc. (CPHI) - 10-K - Current report SEC Filings 03/31/2017
China Pharma Holdings, Inc. (CPHI) - 8-K - Current report SEC Filings 12/28/2016
China Pharma Holdings, Inc. (CPHI) - 8-K - Current report SEC Filings 12/13/2016
China Pharma Holdings, Inc. (CPHI) - 8-K - Current report SEC Filings 12/02/2016
China Pharma Holdings, Inc. (CPHI) - 10-Q - Quarterly Report SEC Filings 11/14/2016
China Pharma Holdings, Inc. (CPHI) - DEFA14A SEC Filings 10/28/2016
China Pharma Holdings, Inc. (CPHI) - DEF 14A SEC Filings 10/28/2016
China Pharma Holdings, Inc. (CPHI) - 10-Q - Quarterly Report SEC Filings 08/11/2016
China Pharma Holdings, Inc. (CPHI) - 10-Q - Quarterly Report SEC Filings 05/16/2016
China Pharma Holdings, Inc. (CPHI) - 10-K - Current report SEC Filings 03/30/2016
China Pharma Holdings, Inc. (CPHI) - 10-Q/A - Quarterly Report SEC Filings 12/28/2015
China Pharma Holdings, Inc. (CPHI) - 10-K/A - Current report SEC Filings 12/28/2015
China Pharma Holdings, Inc. (CPHI) - 8-K - Current report SEC Filings 12/11/2015
China Pharma Holdings, Inc. (CPHI) - 8-K - Current report SEC Filings 12/10/2015
China Pharma Holdings, Inc. (CPHI) - 10-Q - Quarterly Report SEC Filings 11/16/2015
China Pharma Holdings, Inc. (CPHI) - DEFA14A SEC Filings 10/29/2015
China Pharma Holdings, Inc. (CPHI) - DEF 14A SEC Filings 10/29/2015
China Pharma Holdings, Inc. (CPHI) - 10-Q - Quarterly Report SEC Filings 08/14/2015
China Pharma Holdings, Inc. (CPHI) - 10-Q - Quarterly Report SEC Filings 05/11/2015
China Pharma Holdings, Inc. (CPHI) - 10-K - Current report SEC Filings 03/30/2015
China Pharma Holdings, Inc. (CPHI) - 8-K - Current report SEC Filings 12/31/2014
China Pharma Holdings, Inc. (CPHI) - DEFA14C SEC Filings 11/21/2014
China Pharma Holdings, Inc. (CPHI) - DEF 14A SEC Filings 11/20/2014
China Pharma Holdings, Inc. (CPHI) - 10-Q - Quarterly Report SEC Filings 11/14/2014
China Pharma Holdings, Inc. (CPHI) - 10-Q - Quarterly Report SEC Filings 08/14/2014
China Pharma Holdings, Inc. (CPHI) - 10-Q - Quarterly Report SEC Filings 05/15/2014
China Pharma Holdings, Inc. (CPHI) - 10-K - Current report SEC Filings 03/20/2014
China Pharma Holdings, Inc. (CPHI) - 8-K - Current report SEC Filings 12/17/2013
China Pharma Holdings, Inc. (CPHI) - 10-Q - Quarterly Report SEC Filings 11/14/2013
China Pharma Holdings, Inc. (CPHI) - DEFA14A SEC Filings 11/06/2013
China Pharma Holdings, Inc. (CPHI) - DEF 14A SEC Filings 11/06/2013
China Pharma Holdings, Inc. (CPHI) - 8-K - Current report SEC Filings 10/15/2013
China Pharma Holdings, Inc. (CPHI) - 8-K - Current report SEC Filings 09/04/2013
China Pharma Holdings, Inc. (CPHI) - 10-Q - Quarterly Report SEC Filings 08/14/2013
China Pharma Holdings, Inc. (CPHI) - 10-Q - Quarterly Report SEC Filings 05/14/2013
China Pharma Holdings, Inc. (CPHI) - 10-K - Current report SEC Filings 03/14/2013
China Pharma Holdings, Inc. (CPHI) - SC 13G SEC Filings 02/14/2013
China Pharma Holdings, Inc. (CPHI) - SC 13G/A SEC Filings 02/12/2013
China Pharma Holdings, Inc. (CPHI) - 8-K - Current report SEC Filings 01/04/2013
China Pharma Holdings, Inc. (CPHI) - 8-K - Current report SEC Filings 12/26/2012
China Pharma Holdings, Inc. (CPHI) - DEF 14A SEC Filings 11/19/2012
China Pharma Holdings, Inc. (CPHI) - 10-Q - Quarterly Report SEC Filings 11/14/2012
China Pharma Holdings, Inc. (CPHI) - PRE 14A SEC Filings 11/09/2012
China Pharma Holdings, Inc. (CPHI) - 10-Q - Quarterly Report SEC Filings 08/14/2012
China Pharma Holdings, Inc. (CPHI) - 10-Q - Quarterly Report SEC Filings 05/14/2012
China Pharma Holdings, Inc. (CPHI) - 4 SEC Filings 05/01/2012
China Pharma Holdings, Inc. (CPHI) - 8-K - Current report SEC Filings 04/30/2012
China Pharma Holdings, Inc. (CPHI) - 10-K - Current report SEC Filings 03/14/2012
China Pharma Holdings, Inc. (CPHI) - UPLOAD SEC Filings 03/07/2012
China Pharma Holdings, Inc. (CPHI) - CORRESP SEC Filings 03/06/2012
China Pharma Holdings, Inc. (CPHI) - 10-Q/A - Quarterly Report SEC Filings 03/06/2012
China Pharma Holdings, Inc. (CPHI) - 8-K - Current report SEC Filings 03/02/2012
China Pharma Holdings, Inc. (CPHI) - CORRESP SEC Filings 02/28/2012
China Pharma Holdings, Inc. (CPHI) - SC 13G SEC Filings 02/15/2012
China Pharma Holdings, Inc. (CPHI) - SC 13G/A SEC Filings 02/14/2012
China Pharma Holdings, Inc. (CPHI) - CORRESP SEC Filings 02/13/2012
China Pharma Holdings, Inc. (CPHI) - SC 13G/A SEC Filings 02/10/2012
China Pharma Holdings, Inc. (CPHI) - CORRESP SEC Filings 01/17/2012
China Pharma Holdings, Inc. (CPHI) - 8-K - Current report SEC Filings 12/30/2011
China Pharma Holdings, Inc. (CPHI) - CORRESP SEC Filings 12/29/2011
China Pharma Holdings, Inc. (CPHI) - UPLOAD SEC Filings 12/16/2011
China Pharma Holdings, Inc. (CPHI) - DEFA14A SEC Filings 11/23/2011
China Pharma Holdings, Inc. (CPHI) - CORRESP SEC Filings 11/17/2011
China Pharma Holdings, Inc. (CPHI) - DEF 14A SEC Filings 11/14/2011
China Pharma Holdings, Inc. (CPHI) - 10-Q - Quarterly Report SEC Filings 11/10/2011
China Pharma Holdings, Inc. (CPHI) - UPLOAD SEC Filings 11/02/2011
China Pharma Holdings, Inc. (CPHI) - CORRESP SEC Filings 10/24/2011
China Pharma Holdings, Inc. (CPHI) - CORRESP SEC Filings 09/23/2011
China Pharma Holdings, Inc. (CPHI) - UPLOAD SEC Filings 09/13/2011
China Pharma Holdings, Inc. (CPHI) - 10-Q/A - Quarterly Report SEC Filings 09/06/2011
China Pharma Holdings, Inc. (CPHI) - CORRESP SEC Filings 08/19/2011
China Pharma Holdings, Inc. (CPHI) - CORRESP SEC Filings 08/16/2011
China Pharma Holdings, Inc. (CPHI) - 10-Q - Quarterly Report SEC Filings 08/10/2011
China Pharma Holdings, Inc. (CPHI) - CORRESP SEC Filings 08/03/2011
China Pharma Holdings, Inc. (CPHI) - UPLOAD SEC Filings 07/25/2011
China Pharma Holdings, Inc. (CPHI) - 8-K - Current report SEC Filings 06/01/2011
China Pharma Holdings, Inc. (CPHI) - 4 SEC Filings 05/27/2011
China Pharma Holdings, Inc. (CPHI) - 10-Q - Quarterly Report SEC Filings 05/10/2011
China Pharma Holdings, Inc. (CPHI) - 10-K/A - Current report SEC Filings 03/17/2011
China Pharma Holdings, Inc. (CPHI) - 10-Q/A - Quarterly Report SEC Filings 03/15/2011
China Pharma Holdings, Inc. (CPHI) - 10-K - Current report SEC Filings 03/03/2011
China Pharma Holdings, Inc. (CPHI) - 4 SEC Filings 03/02/2011
China Pharma Holdings, Inc. (CPHI) - SC 13G SEC Filings 02/16/2011
China Pharma Holdings, Inc. (CPHI) - SC 13G/A SEC Filings 02/11/2011
China Pharma Holdings, Inc. (CPHI) - SC 13G/A SEC Filings 02/10/2011
China Pharma Holdings, Inc. (CPHI) - 8-K - Current report SEC Filings 12/29/2010
China Pharma Holdings, Inc. (CPHI) - 4 SEC Filings 11/19/2010
China Pharma Holdings, Inc. (CPHI) - DEFA14A SEC Filings 11/12/2010
China Pharma Holdings, Inc. (CPHI) - DEF 14A SEC Filings 11/12/2010
China Pharma Holdings, Inc. (CPHI) - 10-Q - Quarterly Report SEC Filings 11/10/2010
China Pharma Holdings, Inc. (CPHI) - 10-Q - Quarterly Report SEC Filings 08/09/2010
China Pharma Holdings, Inc. (CPHI) - 10-Q - Quarterly Report SEC Filings 05/10/2010
China Pharma Holdings, Inc. (CPHI) - DEF 14C SEC Filings 05/05/2010
China Pharma Holdings, Inc. (CPHI) - UPLOAD SEC Filings 05/03/2010
China Pharma Holdings, Inc. (CPHI) - PRER14C SEC Filings 04/30/2010
China Pharma Holdings, Inc. (CPHI) - UPLOAD SEC Filings 04/26/2010
China Pharma Holdings, Inc. (CPHI) - PRER14C SEC Filings 04/22/2010
China Pharma Holdings, Inc. (CPHI) - CORRESP SEC Filings 04/22/2010
China Pharma Holdings, Inc. (CPHI) - UPLOAD SEC Filings 04/07/2010
China Pharma Holdings, Inc. (CPHI) - PRE 14C SEC Filings 04/01/2010
China Pharma Holdings, Inc. (CPHI) - 10-K - Current report SEC Filings 03/04/2010
China Pharma Holdings, Inc. (CPHI) - EFFECT SEC Filings 02/25/2010
China Pharma Holdings, Inc. (CPHI) - SC 13G/A SEC Filings 02/16/2010
China Pharma Holdings, Inc. (CPHI) - 4 SEC Filings 02/10/2010
China Pharma Holdings, Inc. (CPHI) - POS AM SEC Filings 02/03/2010
China Pharma Holdings, Inc. (CPHI) - EFFECT SEC Filings 01/19/2010
China Pharma Holdings, Inc. (CPHI) - CORRESP SEC Filings 01/12/2010
China Pharma Holdings, Inc. (CPHI) - UPLOAD SEC Filings 01/07/2010
China Pharma Holdings, Inc. (CPHI) - S-3 SEC Filings 12/28/2009
China Pharma Holdings, Inc. (CPHI) - 10-Q - Quarterly Report SEC Filings 11/10/2009
China Pharma Holdings, Inc. (CPHI) - 3 SEC Filings 10/19/2009
China Pharma Holdings, Inc. (CPHI) - 3 SEC Filings 10/16/2009
China Pharma Holdings, Inc. (CPHI) - 4 SEC Filings 10/15/2009
China Pharma Holdings, Inc. (CPHI) - 8-K - Current report SEC Filings 10/01/2009
China Pharma Holdings, Inc. (CPHI) - 424B3 SEC Filings 10/01/2009
China Pharma Holdings, Inc. (CPHI) - 3 SEC Filings 09/30/2009
China Pharma Holdings, Inc. (CPHI) - CERTNYS SEC Filings 09/29/2009
China Pharma Holdings, Inc. (CPHI) - 8-A12B SEC Filings 09/28/2009
China Pharma Holdings, Inc. (CPHI) - 424B3 SEC Filings 09/28/2009
China Pharma Holdings, Inc. (CPHI) - DEFR14C SEC Filings 09/23/2009
China Pharma Holdings, Inc. (CPHI) - DEF 14C SEC Filings 09/23/2009
China Pharma Holdings, Inc. (CPHI) - PRE 14C SEC Filings 09/15/2009
China Pharma Holdings, Inc. (CPHI) - 8-K - Current report SEC Filings 09/04/2009
China Pharma Holdings, Inc. (CPHI) - PRE 14C SEC Filings 09/03/2009
China Pharma Holdings, Inc. (CPHI) - 8-K - Current report SEC Filings 08/28/2009
China Pharma Holdings, Inc. (CPHI) - 10-Q - Quarterly Report SEC Filings 08/11/2009
China Pharma Holdings, Inc. (CPHI) - UPLOAD SEC Filings 07/23/2009
China Pharma Holdings, Inc. (CPHI) - 424B3 SEC Filings 06/30/2009
China Pharma Holdings, Inc. (CPHI) - DEF 14C SEC Filings 06/25/2009
China Pharma Holdings, Inc. (CPHI) - CORRESP SEC Filings 06/24/2009
China Pharma Holdings, Inc. (CPHI) - 10-Q/A - Quarterly Report SEC Filings 06/24/2009
China Pharma Holdings, Inc. (CPHI) - 10-K/A - Current report SEC Filings 06/24/2009
China Pharma Holdings, Inc. (CPHI) - PRE 14C SEC Filings 06/22/2009
China Pharma Holdings, Inc. (CPHI) - 10-Q - Quarterly Report SEC Filings 05/14/2009
China Pharma Holdings, Inc. (CPHI) - 424B3 SEC Filings 05/04/2009
China Pharma Holdings, Inc. (CPHI) - 8-K - Current report SEC Filings 04/30/2009
China Pharma Holdings, Inc. (CPHI) - UPLOAD SEC Filings 03/27/2009
China Pharma Holdings, Inc. (CPHI) - 424B3 SEC Filings 03/23/2009
China Pharma Holdings, Inc. (CPHI) - 10-K - Current report SEC Filings 03/17/2009
China Pharma Holdings, Inc. (CPHI) - CORRESP SEC Filings 03/12/2009
China Pharma Holdings, Inc. (CPHI) - 10KSB/A SEC Filings 03/12/2009
China Pharma Holdings, Inc. (CPHI) - 10-Q/A - Quarterly Report SEC Filings 03/12/2009
China Pharma Holdings, Inc. (CPHI) - SC 13G/A SEC Filings 02/13/2009
China Pharma Holdings, Inc. (CPHI) - 8-K - Current report SEC Filings 12/29/2008
China Pharma Holdings, Inc. (CPHI) - UPLOAD SEC Filings 12/23/2008
China Pharma Holdings, Inc. (CPHI) - 10-Q - Quarterly Report SEC Filings 11/06/2008
China Pharma Holdings, Inc. (CPHI) - 424B3 SEC Filings 08/14/2008
China Pharma Holdings, Inc. (CPHI) - EFFECT SEC Filings 08/13/2008
China Pharma Holdings, Inc. (CPHI) - CORRESP SEC Filings 08/07/2008
China Pharma Holdings, Inc. (CPHI) - 10QSB SEC Filings 08/05/2008
China Pharma Holdings, Inc. (CPHI) - CORRESP SEC Filings 08/04/2008
China Pharma Holdings, Inc. (CPHI) - S-1/A SEC Filings 07/29/2008
China Pharma Holdings, Inc. (CPHI) - UPLOAD SEC Filings 07/15/2008
China Pharma Holdings, Inc. (CPHI) - S-1 SEC Filings 07/11/2008
China Pharma Holdings, Inc. (CPHI) - DEF 14C SEC Filings 07/11/2008
China Pharma Holdings, Inc. (CPHI) - UPLOAD SEC Filings 07/10/2008
China Pharma Holdings, Inc. (CPHI) - CORRESP SEC Filings 07/10/2008
China Pharma Holdings, Inc. (CPHI) - UPLOAD SEC Filings 07/02/2008
China Pharma Holdings, Inc. (CPHI) - PRE 14C SEC Filings 06/27/2008
China Pharma Holdings, Inc. (CPHI) - 8-K - Current report SEC Filings 06/27/2008
China Pharma Holdings, Inc. (CPHI) - SC 13G SEC Filings 06/09/2008
China Pharma Holdings, Inc. (CPHI) - 8-K - Current report SEC Filings 05/28/2008
China Pharma Holdings, Inc. (CPHI) - 10QSB SEC Filings 04/30/2008
China Pharma Holdings, Inc. (CPHI) - 10KSB SEC Filings 03/31/2008
China Pharma Holdings, Inc. (CPHI) - 8-K - Current report SEC Filings 02/28/2008
China Pharma Holdings, Inc. (CPHI) - 8-K - Current report SEC Filings 02/04/2008
China Pharma Holdings, Inc. (CPHI) - 10QSB SEC Filings 11/14/2007
China Pharma Holdings, Inc. (CPHI) - SC 13D/A SEC Filings 11/13/2007
China Pharma Holdings, Inc. (CPHI) - 4 SEC Filings 11/08/2007
China Pharma Holdings, Inc. (CPHI) - 10QSB SEC Filings 08/13/2007
China Pharma Holdings, Inc. (CPHI) - 10QSB SEC Filings 05/15/2007
China Pharma Holdings, Inc. (CPHI) - 424B3 SEC Filings 05/08/2007
China Pharma Holdings, Inc. (CPHI) - EFFECT SEC Filings 05/07/2007
China Pharma Holdings, Inc. (CPHI) - CORRESP SEC Filings 05/03/2007
China Pharma Holdings, Inc. (CPHI) - SB-2/A SEC Filings 04/24/2007
China Pharma Holdings, Inc. (CPHI) - UPLOAD SEC Filings 04/17/2007
China Pharma Holdings, Inc. (CPHI) - SB-2/A SEC Filings 04/03/2007
China Pharma Holdings, Inc. (CPHI) - SB-2 SEC Filings 03/30/2007
China Pharma Holdings, Inc. (CPHI) - 10KSB SEC Filings 03/28/2007
China Pharma Holdings, Inc. (CPHI) - SC 13G/A SEC Filings 02/14/2007
China Pharma Holdings, Inc. (CPHI) - 8-K - Current report SEC Filings 02/06/2007
China Pharma Holdings, Inc. (CPHI) - 10QSB SEC Filings 11/13/2006
China Pharma Holdings, Inc. (CPHI) - 10KSB/A SEC Filings 11/08/2006
China Pharma Holdings, Inc. (CPHI) - SC 13D/A SEC Filings 09/25/2006
China Pharma Holdings, Inc. (CPHI) - SC 13D SEC Filings 09/25/2006
China Pharma Holdings, Inc. (CPHI) - 8-K - Current report SEC Filings 09/21/2006
China Pharma Holdings, Inc. (CPHI) - 4 SEC Filings 09/14/2006
China Pharma Holdings, Inc. (CPHI) - 10QSB SEC Filings 08/14/2006
China Pharma Holdings, Inc. (CPHI) - 4 SEC Filings 05/16/2006
China Pharma Holdings, Inc. (CPHI) - 10QSB SEC Filings 05/15/2006
China Pharma Holdings, Inc. (CPHI) - 8-K - Current report SEC Filings 05/04/2006
China Pharma Holdings, Inc. (CPHI) - 10KSB SEC Filings 03/31/2006
China Pharma Holdings, Inc. (CPHI) - DEF 14C SEC Filings 03/28/2006
China Pharma Holdings, Inc. (CPHI) - 424B3 SEC Filings 03/16/2006
China Pharma Holdings, Inc. (CPHI) - PRER14C SEC Filings 03/15/2006
China Pharma Holdings, Inc. (CPHI) - SC 13D SEC Filings 03/06/2006
China Pharma Holdings, Inc. (CPHI) - CORRESP SEC Filings 02/01/2006
China Pharma Holdings, Inc. (CPHI) - PRE 14C SEC Filings 01/25/2006
China Pharma Holdings, Inc. (CPHI) - CORRESP SEC Filings 01/25/2006
China Pharma Holdings, Inc. (CPHI) - 3 SEC Filings 12/28/2005
China Pharma Holdings, Inc. (CPHI) - SB-2/A SEC Filings 12/23/2005
China Pharma Holdings, Inc. (CPHI) - 10QSB SEC Filings 11/18/2005
China Pharma Holdings, Inc. (CPHI) - SB-2/A SEC Filings 11/16/2005
China Pharma Holdings, Inc. (CPHI) - NT 10-Q - Quarterly Report SEC Filings 11/14/2005
China Pharma Holdings, Inc. (CPHI) - SC 13G SEC Filings 10/27/2005
China Pharma Holdings, Inc. (CPHI) - UPLOAD SEC Filings 10/26/2005
China Pharma Holdings, Inc. (CPHI) - SB-2 SEC Filings 10/20/2005
China Pharma Holdings, Inc. (CPHI) - 8-K - Current report SEC Filings 10/20/2005
China Pharma Holdings, Inc. (CPHI) - SC 13D SEC Filings 10/04/2005
China Pharma Holdings, Inc. (CPHI) - 4 SEC Filings 10/04/2005
China Pharma Holdings, Inc. (CPHI) - 3 SEC Filings 10/04/2005
China Pharma Holdings, Inc. (CPHI) - 10KSB SEC Filings 09/23/2005
China Pharma Holdings, Inc. (CPHI) - CORRESP SEC Filings 08/23/2005
China Pharma Holdings, Inc. (CPHI) - UPLOAD SEC Filings 08/19/2005
China Pharma Holdings, Inc. (CPHI) - 8-K - Current report SEC Filings 08/18/2005
China Pharma Holdings, Inc. (CPHI) - SC 13D SEC Filings 05/11/2005
China Pharma Holdings, Inc. (CPHI) - 8-K - Current report SEC Filings 05/11/2005
China Pharma Holdings, Inc. (CPHI) - 3 SEC Filings 05/11/2005
China Pharma Holdings, Inc. (CPHI) - 10QSB SEC Filings 05/09/2005
China Pharma Holdings, Inc. (CPHI) - 8-K - Current report SEC Filings 03/29/2005
China Pharma Holdings, Inc. (CPHI) - 10QSB SEC Filings 02/22/2005
China Pharma Holdings, Inc. (CPHI) - NT 10-Q - Quarterly Report SEC Filings 02/14/2005
China Pharma Holdings, Inc. (CPHI) - 10QSB SEC Filings 11/24/2004
China Pharma Holdings, Inc. (CPHI) - NTN 10Q SEC Filings 11/15/2004
China Pharma Holdings, Inc. (CPHI) - NT 10-Q - Quarterly Report SEC Filings 11/15/2004
China Pharma Holdings, Inc. (CPHI) - 10KSB SEC Filings 10/14/2004
China Pharma Holdings, Inc. (CPHI) - 8-K/A - Current report SEC Filings 10/04/2004
China Pharma Holdings, Inc. (CPHI) - NT 10-K - Current report SEC Filings 09/27/2004
China Pharma Holdings, Inc. (CPHI) - 8-K - Current report SEC Filings 08/20/2004
China Pharma Holdings, Inc. (CPHI) - 10QSB SEC Filings 05/17/2004
China Pharma Holdings, Inc. (CPHI) - 10KSB/A SEC Filings 03/25/2004
China Pharma Holdings, Inc. (CPHI) - 8-K/A - Current report SEC Filings 03/09/2004
China Pharma Holdings, Inc. (CPHI) - 10QSB SEC Filings 02/18/2004
China Pharma Holdings, Inc. (CPHI) - NT 10-Q - Quarterly Report SEC Filings 02/17/2004
China Pharma Holdings, Inc. (CPHI) - 8-K - Current report SEC Filings 02/06/2004
China Pharma Holdings, Inc. (CPHI) - AW SEC Filings 01/20/2004
China Pharma Holdings, Inc. (CPHI) - PRER14C SEC Filings 12/08/2003
China Pharma Holdings, Inc. (CPHI) - 10KSB/A SEC Filings 12/08/2003
China Pharma Holdings, Inc. (CPHI) - 10QSB SEC Filings 11/19/2003
China Pharma Holdings, Inc. (CPHI) - NT 10-Q - Quarterly Report SEC Filings 11/17/2003
China Pharma Holdings, Inc. (CPHI) - 10KSB SEC Filings 10/14/2003
China Pharma Holdings, Inc. (CPHI) - PRER14C SEC Filings 10/10/2003
China Pharma Holdings, Inc. (CPHI) - PRE 14C SEC Filings 10/09/2003
China Pharma Holdings, Inc. (CPHI) - NT 10-K - Current report SEC Filings 09/25/2003
China Pharma Holdings, Inc. (CPHI) - 10KSB/A SEC Filings 08/29/2003
China Pharma Holdings, Inc. (CPHI) - PRE 14C SEC Filings 08/20/2003
China Pharma Holdings, Inc. (CPHI) - 8-K - Current report SEC Filings 08/18/2003
China Pharma Holdings, Inc. (CPHI) - 10QSB SEC Filings 05/20/2003
China Pharma Holdings, Inc. (CPHI) - NT 10-Q - Quarterly Report SEC Filings 05/16/2003
China Pharma Holdings, Inc. (CPHI) - 10QSB SEC Filings 02/19/2003
China Pharma Holdings, Inc. (CPHI) - NT 10-Q - Quarterly Report SEC Filings 02/13/2003
China Pharma Holdings, Inc. (CPHI) - 10KSB/A SEC Filings 01/27/2003
China Pharma Holdings, Inc. (CPHI) - 10QSB SEC Filings 11/19/2002
China Pharma Holdings, Inc. (CPHI) - NT 10-Q - Quarterly Report SEC Filings 11/12/2002
China Pharma Holdings, Inc. (CPHI) - 10KSB/A SEC Filings 10/21/2002
China Pharma Holdings, Inc. (CPHI) - 10KSB SEC Filings 10/15/2002
China Pharma Holdings, Inc. (CPHI) - NT 10-K - Current report SEC Filings 09/26/2002
China Pharma Holdings, Inc. (CPHI) - 8-K - Current report SEC Filings 09/11/2002
China Pharma Holdings, Inc. (CPHI) - 10QSB SEC Filings 05/20/2002
China Pharma Holdings, Inc. (CPHI) - NT 10-Q - Quarterly Report SEC Filings 05/16/2002
China Pharma Holdings, Inc. (CPHI) - 10QSB SEC Filings 02/08/2002
China Pharma Holdings, Inc. (CPHI) - 10QSB SEC Filings 11/19/2001
China Pharma Holdings, Inc. (CPHI) - NT 10-Q - Quarterly Report SEC Filings 11/15/2001
China Pharma Holdings, Inc. (CPHI) - 8-K/A - Current report SEC Filings 10/26/2001
China Pharma Holdings, Inc. (CPHI) - 8-K - Current report SEC Filings 08/27/2001
China Pharma Holdings, Inc. (CPHI) - 10QSB SEC Filings 08/14/2001
China Pharma Holdings, Inc. (CPHI) - 8-K - Current report SEC Filings 08/08/2001
China Pharma Holdings, Inc. (CPHI) - 10QSB SEC Filings 05/01/2001
China Pharma Holdings, Inc. (CPHI) - 10KSB SEC Filings 03/30/2001
China Pharma Holdings, Inc. (CPHI) - 10QSB SEC Filings 11/13/2000
China Pharma Holdings, Inc. (CPHI) - 10QSB SEC Filings 08/07/2000
China Pharma Holdings, Inc. (CPHI) - 10QSB SEC Filings 05/11/2000
China Pharma Holdings, Inc. (CPHI) - 10SB12G/A SEC Filings 04/21/2000
China Pharma Holdings, Inc. (CPHI) - 10SB12G/A SEC Filings 04/04/2000
China Pharma Holdings, Inc. (CPHI) - 10SB12G SEC Filings 02/15/2000

Press Releases

StockPrice Release
China pharma holdings inc. announces 1-for-5 reverse stock split 02/23/2024
China pharma holdings, inc. announced the completion of third party testing of dry eye disease therapeutic device 11/29/2023
China pharma's candesartan hypertension product passes the quality and efficacy consistency evaluation of generic drugs 08/09/2023
China pharma holdings inc. announces 1-for-10 reverse stock split 02/24/2023
China pharma holdings, inc. announced the launch of n95 medical protective mask 12/28/2022
China pharma holdings, inc. announced that several products are included in the catalogue of medicines for people infected with covid-19 12/15/2022
China pharma holdings, inc. announced the acquisition of dry eye disease therapeutic device project 12/05/2022
China pharma announces receipt of noncompliance notice from nyse american 12/02/2022
China pharma announces receipt of notification of nyse american listing deficiency 10/01/2022
China pharma announces receipt of noncompliance notice from nyse american 06/22/2022
China pharma holdings, inc. reports third quarter 2021 financial results 11/12/2021
China pharma holdings, inc. reports second quarter 2021 financial results 08/13/2021
China pharma's candesartan hypertension product passes bioequivalence tests and the company plans to apply for nmpa approval 08/05/2021
China pharma to launch highly purified nmn+pqq product 06/09/2021
China pharma holdings, inc. reports 33% yoy increase in first quarter 2021 revenue 05/14/2021
China pharma expects considerable increase in growth opportunities related to hainan free trade port 04/19/2021
China pharma holdings, inc. reports fiscal year 2020 financial results 03/26/2021
China pharma holdings inc q2 revenue rose 46.8 percent to $3.8 million 08/14/2020
Animal parasiticides market by product, animal, and end-user - global forecast to 2025 - researchandmarkets.com 07/13/2020
Cardiac implantable electronic device market to surpass us$ 38,027.8 million globally by end of 2027, says cmi 06/29/2020
China pharma holdings reports first quarter 2020 financial results 05/15/2020
Global companion diagnostics market (2020 to 2030) - focus on technology, application area, country data and competitive landscape - researchandmarkets.com 05/14/2020
China pharma holdings q3 loss per share $0.02 11/15/2019
China pharma holdings, inc. reports earnings results for the third quarter ended september 30, 2019 11/13/2019

More Headlines

News
China Pharma Expects Considerable Increase in Growth Opportunities Related to Hainan Free Trade Port HAIKOU, China, April 19, 2021 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), a specialty pharmaceutical company, commented on the policy statements in "Several Special Measures to Support the Construction of Hainan Free Trade Port to Relax Market Access" released by the National Development and Reform Commission and the Ministry of Commerce in April. This statement follows the release of the Overall Plan for the Construction of Hainan Free Trade Port in June 2020 and the establishment of the Hainan Boao Lecheng International Medical Tourism Pilot District in 2013, which were both approved by the State Council. 04/19/2021
Top Penny Stocks Today: What to Know About BAYP, SEAC, UPC, CPHI, CYAN Stocks Shares of several penny stocks are on the rise today as Reddit investors continue to pick out the top ones to take a risk on. The post Top Penny Stocks Today: What to Know About BAYP, SEAC, UPC, CPHI, CYAN Stocks appeared first on InvestorPlace. 03/29/2021
China Pharma Holdings, Inc. Reports Fiscal Year 2020 Financial Results HAIKOU CITY, China , March 26, 2021 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based in China, today announced financial results for the fiscal year ended December 31, 20 20 . Full Year Highlights Revenue was both $10.9 million in fiscal year 2020 and 2019 , respectively ; Gross margin was 1 8.0 % in fiscal year 20 20 , compared to 1 3.6 % in fiscal year 201 9; Loss from operations was $2 .6 million in fiscal year 20 20 compared to $ 2 0.4 million in fiscal year 201 9 , which represented a n improvement of $ 17.8 million; Net loss was $2 .9 million in fiscal year 20 20 compared to $ 20.7 million in fiscal year 201 9. 03/26/2021
China Pharma Holdings, Inc. Reports Second Quarter 2020 Financial Results China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based in China, today announced financial results for the quarter ended June 30, 2020. 08/14/2020
CPHI to Hold Second Quarter 2020 Earnings Conference Call On Friday August 14, 2020 at 8:30 a.m. ET China Pharmaceutical Holdings Limited (NYSE American: CPHI) ("China Pharma" or "Company"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based in China, today announced that it plans to hold its 2nd quarter 2020 earnings conference call on Friday, August 14, 2020 at 8:30 a.m. ET. 08/11/2020
China Pharma (NYSEAMERICAN:CPHI) Stock Crosses Above 200 Day Moving Average of $0.00 China Pharma Holdings, Inc. (NYSEAMERICAN:CPHI) passed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $0.00 and traded as high as $0.57. China Pharma shares last traded at $0.57, with a volume of 384,000 shares trading hands. China Pharma (NYSEAMERICAN:CPHI) last issued its quarterly earnings results […] 07/22/2020
Animal Parasiticides Market by Product, Animal, and End-user - Global Forecast to 2025 - ResearchAndMarkets.com The 07/13/2020
China Pharma Holdings, Inc. (NYSEAMERICAN:CPHI) Sees Large Increase in Short Interest China Pharma Holdings, Inc. (NYSEAMERICAN:CPHI) saw a significant growth in short interest in the month of June. As of June 30th, there was short interest totalling 253,900 shares, a growth of 102.1% from the June 15th total of 125,600 shares. Currently, 1.2% of the shares of the company are sold short. Based on an average […] 07/06/2020
Cardiac Implantable Electronic Device Market to Surpass US$ 38,027.8 Million Globally by End of 2027, Says CMI 06/29/2020
Cardiac Implantable Electronic Device Market to Surpass US$ 38,027.8 Million Globally by End of 2027, Says CMI Cardiac implantable electronic device market valued at US$ 22,576.22 million in 2020 and is expected to grow at CAGR of 7.7%. 06/29/2020
Hikma Pharmaceuticals (OTCMKTS:HKMPF) Stock Rating Upgraded by Zacks Investment Research Hikma Pharmaceuticals (OTCMKTS:HKMPF) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research note issued on Wednesday, Zacks.com reports. The brokerage currently has a $32.00 price objective on the stock. Zacks Investment Research‘s price objective suggests a potential upside of 13.07% from the company’s current price. According to […] 06/26/2020
Drug Delivery Systems Market to Hit USD 45.20 Billion by 2027; Rising Demand for Efficient Drug Delivery for Complex Conditions to Fuel the Market: Fortune Business Insights™ The global drug delivery systems market size is projected to reach USD 45.20 billion by 2027, exhibiting a CAGR of 6.8% during the forecast period. Increasing 06/25/2020
Is A2 Milk Company going to acquire another infant formula company? The A2 Milk Company Ltd (ASX:A2M) share price is dropping lower today amid speculation it could be buying a rival infant formula company... 06/22/2020
China Pharma (NYSEAMERICAN:CPHI) Shares Gap Down to $0.58 China Pharma Holdings, Inc. (NYSEAMERICAN:CPHI) shares gapped down before the market opened on Wednesday . The stock had previously closed at $0.56, but opened at $0.58. China Pharma shares last traded at $0.58, with a volume of 918,483 shares traded. China Pharma (NYSEAMERICAN:CPHI) last released its earnings results on Tuesday, March 31st. The company reported […] 06/19/2020
Short Interest in China Pharma Holdings, Inc. (NYSEAMERICAN:CPHI) Drops By 33.8% China Pharma Holdings, Inc. (NYSEAMERICAN:CPHI) was the target of a significant drop in short interest during the month of June. As of June 15th, there was short interest totalling 125,600 shares, a drop of 33.8% from the May 31st total of 189,700 shares. Currently, 0.6% of the company’s shares are sold short. Based on an […] 06/19/2020
Edited Transcript of CPHI earnings conference call or presentation 15-May-20 12:30pm GMT Q1 2020 China Pharma Holdings Inc Earnings Call 06/04/2020
MAFS Susie Bradley marks one year of her injectable cosmetics business Susie Bradley rose to fame on last year's iconic season Married At First Sight. 05/22/2020
Ocular Inflammation Treatment Market Analysis as per the Latest Coronavirus Impact May 20, 2020 (Heraldkeepers) -- New York, May 20, 2020: You will get latest updated report as per the COVID-19 Impact on this industry. Our updated reports... 05/20/2020
Asia Pacific Biopharmaceutical Contract Manufacturing Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product ; Service, and Geography New York, May 19, May 19, 2020 (GLOBE NEWSWIRE via COMTEX) -- New York, May 19, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report... 05/20/2020
China Pharma Holding Q1 EPS $(0.020) Down From $(0.010) YoY, Sales $1.800M Down From $2.929M YoY 05/15/2020
China Pharma Holdings, Inc. Reports First Quarter 2020 Financial Results China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based in China, today announced financial results for the quarter ended March 31, 2020. 05/15/2020
China Pharma Holdings, Inc. Reports First Quarter —…—… Financial Results 05/15/2020
Global Companion Diagnostics Market (2020 to 2030) - Focus on Technology, Application Area, Country Data and Competitive Landscape - ResearchAndMarkets.com The 05/14/2020
Hikma Pharmaceuticals : responds to COVID-19 shortage with launch of Propofol Injectable Emulsion, USP \| MarketScreener 05/13/2020
Medical Writing Market is expected to cross USD 3.25 Billion by 2025 ,Growth Opportunity During COVID-19 May 11, 2020 (AmericaNewsHour) -- Market Synopsis The Global Medical Writing Market is expected to cross USD 3.25 Billion by 2025 at a CAGR of 10.1... 05/11/2020
36 Stocks Moving in Thursday's Pre-Market Session 05/07/2020
China Pharmaceutical Holdings Subsidiary Launches Mask Production Lines 04/15/2020
China Pharmaceutical Holdings Co., Ltd. Added Mask Production Lines China Pharmaceutical Holdings Limited (NYSE American: CPHI) ("China Pharma" or "Company"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based in China, today announced that its subsidiary, Hainan Helpson Pharmaceutical & Biotechnology Co., Ltd. ("Helpson") launched mask production lines. 04/15/2020
China Pharmaceutical Holdings Co., Ltd. Added Mask Production Lines 04/15/2020
China Pharma Reports FY19 Sales Of $11 Million An 11.4% Decrease From Last Year 04/14/2020
Updates - China Pharma Holdings, Inc. Reports Fiscal Year 2019 Financial Results China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based in China, today announced that it is re-issuing its previous release that was made on March 31, 2020 to incorporate certain disclosures that are required under the NYSE American Company Guide Sections 401(h) and 610(b). Included below are these additional disclosures along with the previously disclosed financial results for the fiscal year ended December 31, 2019. 04/14/2020
How Much is China Pharma Holdings, Inc.'s (NYSEMKT:CPHI) CEO Getting Paid? In 2005 Zhilin Li was appointed CEO of China Pharma Holdings, Inc. (NYSEMKT:CPHI). This analysis aims first to... 04/14/2020
Dr Boreham's Crucible: TBG is trying to surf the COVID-19 wave before the market floods - Stockhead As could be expected, the molecular diagnostics house’s announcement of European approval of its Chinese investee company’s COVID-19 test was greeted with a powerful share rally. The trouble is, some investors appear to have developed psychic powers and weighed in before the European regulator’s approval was announced to the market on Wednesday March 18. TBG … 04/13/2020
Edited Transcript of CPHI earnings conference call or presentation 31-Mar-20 12:30pm GMT Q4 2019 China Pharma Holdings Inc Earnings Call 04/05/2020
The Daily Biotech Pulse: Amarin Faces Legal Setback, Milestone Payment Kicks In For CytomX, Savara, Reata Disclose COVID-19 Disruptions Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs March 30.) * Athersys Inc (NASDAQ: ATHX) (reacted to $7-million capital injection by Japanese partner) * Quidel Corporation (NASDAQ: QDEL)Down In The Dumps ( 03/31/2020
China Pharma Holdings, Inc. Reports Fiscal Year 2019 Financial Results China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based in China, today announced financial results for the fiscal year ended December 31, 2019. 03/31/2020
The Week Ahead In Biotech: Clinical Readouts, COVID-19 News Flow In Focus Amid Continuing Uncertainty After starting the week ended March 28 on the backfoot, biotech stocks recovered through the week. Activity in the space remained light, although coronavirus (COVID-19) news flow continued to dominate.Here are the key catalysts that may impact biotech stocks in the unfolding week.Conferences Most conferences 03/29/2020
CPHI to Hold Fiscal Year 2019 Earnings Conference Call On Tuesday March 31, 2020 at 8:30 a.m. ET China Pharmaceutical Holdings Limited (NYSE American: CPHI) ("China Pharma" or "Company"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based in China, today announced that it plans to hold its fiscal year 2019 earnings conference call on Tuesday, March 31, 2020 at 8:30 a.m. ET. 03/13/2020
CPHI to Hold Fiscal Year —…–9 Earnings Conference Call On Tuesday March '–, ... 03/13/2020
85 Biggest Movers From Yesterday Gainers Inovio Pharmaceuticals, Inc. (NASDAQ: INO) shares climbed 69.7% to close at $7.45. Inovio Pharmaceuticals announced an accelerated timeline Tuesday for the development of... 03/04/2020
Mid-Afternoon Market Update: Dow Tumbles 800 Points; Superconductor Technologies Shares Spike Higher Toward the end of trading Tuesday, the Dow traded down 3.03% to 25893.26 while the NASDAQ fell 3.13% to 8,672.22. The S&P also fell, dropping 2.87% to 3,001.43. Coronavirus... 03/03/2020
Coronavirus plays - vaccines, drugs & infection control products Below are companies that have announced plans to develop either vaccines or therapies for COVID-19. Again, some are more credible than others.Vaccines: Sanofi (SNY -1.5%), iBio (IBIO -10.2%), Vaxart ( 03/03/2020
Mid-Day Market Update: Dow Falls Over 200 Points; Fed Issues Emergency Interest Rate Cut Midway through trading Tuesday, the Dow traded down 0.77% to 26497.47 while the NASDAQ fell 0.37% to 8,919.22. The S&P also fell, dropping 0.49% to 3,075.01. Coronavirus cases... 03/03/2020
50 Stocks Moving In Tuesday's Mid-Day Session Gainers Superconductor Technologies Inc. (NASDAQ: SCON) shares jumped 107.1% to $0.4079. Superconductor Technologies and Allied Integral United announced a merger agreement.... 03/03/2020
40 Stocks Moving in Tuesday's Pre-Market Session Gainers Superconductor Technologies Inc. (NASDAQ: SCON) shares rose 123.3% to $0.44 in pre-market trading. Superconductor Technologies and Allied Integral United announced a... 03/03/2020
108 Biggest Movers From Yesterday 03/03/2020
China Pharmaceutical Holdings Co., Ltd. Launched A New Product China Pharmaceutical Holdings Limited (NYSE American: CPHI) ("China Pharma" or "Company"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based in China, today announced that its subsidiary, Hainan Helpson Pharmaceutical & Biotechnology Co., Ltd. ("Helpson") launched a new product – the wash-free sanitizer. 03/02/2020
Mid-Afternoon Market Update: Dow Jumps 800 Points; China Pharma Shares Spike Higher 03/02/2020
Shares of several US-listed Chinese companies are trading lower despite overall market optimism amid reports of progress towards a coronavirus treatment. NOTE: Coronavirus fears in China still exist and the WHO said there is no known treatment currently. 02/05/2020
85 Biggest Movers From Yesterday Gainers China Pharma Holdings, Inc. (NYSE: CPHI) shares climbed 96.5% to close at $0.92 on Monday after gaining 11.50% on Friday. Gulf Resources, Inc. (NASDAQ: GURE) shares... 02/04/2020
61 Stocks Moving In Monday's Mid-Day Session Gainers China Pharma Holdings, Inc. (NYSE: CPHI) shares jumped 88% to $0.88 after gaining 11.50% on Friday. Artelo Biosciences, Inc. (NASDAQ: ARTL) shares climbed 50.3% to $3.05... 02/03/2020
30 Stocks Moving in Monday's Pre-Market Session 02/03/2020
Coronavirus update: Vaccine stocks retreat and airport screening expands to 20 U.S. airports A nearly weeklong rally for vaccine and diagnostics developers looking to capitalize on the coronavirus outbreak ended on Tuesday. 01/28/2020
Baby formula stocks ASX Guide \| Stockhead Read the ultimate guide on Australian baby formula stocks, dairy and milk companies and pricing from Stockhead's leading journalists. 01/01/2020
China Pharma Holdings, Inc. (NYSEMKT:CPHI): What Does Its Beta Value Mean For Your Portfolio? If you're interested in China Pharma Holdings, Inc. (NYSEMKT:CPHI), then you might want to consider its beta (a... 12/31/2019
China Pharma Holdings, Inc. Reports Third Quarter 2019 Financial Results HAIKOU CITY, China , Nov. 15, 2019 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American-listed corporation ... 11/15/2019
China Pharma Holding Q3 EPS $(0.02) Up From $(0.04) YoY, Sales $2.4M Up From $2.298M YoY 11/15/2019
Introducing China Pharma Holdings (NYSEMKT:CPHI), A Stock That Climbed 37% In The Last Three Years Buying a low-cost index fund will get you the average market return. But if you invest in individual stocks, some are... 10/28/2019
Our Take On China Pharma Holdings, Inc.'s (NYSEMKT:CPHI) CEO Salary In 2005 Zhilin Li was appointed CEO of China Pharma Holdings, Inc. (NYSEMKT:CPHI). This report will, first, examine... 09/13/2019
China Pharma Holdings, Inc. Has Entered into A Memorandum of Understanding With World Health Advanced Technologies, Ltd. HAIKOU CITY, China, Sept. 11, 2019 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," "CPHI", the "Company" or "We"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based in China, today announced that it has entered into a Memorandum of Understanding (MOU) and the Addendum with World Health Advanced Technologies, Ltd (W.H.A.T.) to advance the scientific success of ENERCEL® on an exclusive basis in China. Chinese government has had the foresight to approve and develop the Free Trade Zone of Hainan Island. 09/11/2019
China Pharma Holdings, Inc. Has Entered into A Memorandum of Understanding With World Health Advanced Technologies, Ltd. To Advance ENERCEL On An Exclusive Basis In China 09/11/2019
Edited Transcript of CPHI earnings conference call or presentation 15-Aug-19 12:30pm GMT Q2 2019 China Pharma Holdings Inc Earnings Call 09/06/2019
China Pharma Holdings, Inc. Reports Second Quarter 2019 Financial Results HAIKOU, China , Aug. 15, 2019 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American-listed corporation ... 08/15/2019
China Pharma Holding Q2 EPS $(0.02), Same YoY, Sales $2.569M Down From $3.174M YoY 08/15/2019
China Pharma Holding Q1 EPS $(0.01), Same YoY, Sales $2.9M Down From $3.616M YoY 05/15/2019
China Pharma Holdings, Inc. FY18 EPS $(0.25) vs $(0.44) In FY17, Sales $12.3M vs $13.2M Year Over Year 03/29/2019
China Pharma Holding Q3 EPS $(0.04) Up From $(0.05) YoY, Sales $2.298M Down From $3.162M YoY 11/15/2018
China Pharma Holdings, Inc. Launched Health Product Noni Enzyme ARARATO® 11/13/2018
China Pharma Holding Q2 EPS $(0.02) Up From $(0.05) YoY, Sales $3.17M Up From $2.917M YoY 08/15/2018
China Pharma Holdings' (CPHI) CEO Zhilin Li on Q1 2018 Results - Earnings Call Transcript 05/15/2018
Baby Food: Unveiling Global Growth Drivers & Premiumisation Strategies Growing-up milk formula continues to generate the majority of growth in milk formula, as it is less vulnerable to awareness of breastfeeding’s benefits. 05/01/2018
China Pharma reports FY results 04/03/2018
China Pharma Holdings Shares Resume, Pullback From Highs, Up 435% 01/05/2018
China Pharma Holdings Reports Q3 EPS $(0.05) vs $(0.04) In Same Qtr. Last Year, Sales $3.2M vs $3.1M YoY 11/15/2017
KPCB’s James Huang Says High Healthcare Valuations Force Investors To Seek Early Stage Innovation KPCB's James Huang Says High Healthcare Valuations Force Investors To Seek Early Stage Innovation – China Money Network - China Money Network 10/18/2017
China Pharma Holdings Q2 EPS $(0.05) from $(0.06) YoY, Sales $2.92M vs $3.54M YoY 08/15/2017
China Pharma Holdings Reports Q1 EPS $(0.02) vs $(0.04) In Same Qtr. Last Year, Sales $3.3M vs $3.6M YoY 05/12/2017
China Pharma Holdings Reports FY16 EPS $(0.21) vs $(0.35) in Same Qtr. Last Year, Sales $15.6M 03/31/2017
China Pharma Holdings Q3 EPS $(0.04), Revenue $3.13M, No Estimates 11/15/2016
China Pharma Reports Q2 EPS $(0.06) vs $0.03 in Same Qtr. Last Year, Sales $3.5M 08/12/2016
Register For China-Israel Investment Summit To Meet Top Investors, Government Officials And Entrepreneurs 30,000 Feet Up In The Air Register For China-Israel Investment Summit To Meet Top Investors, Government Officials And Entrepreneurs 30,000 Feet Up In The Air – China Money Network - China Money Network 08/09/2016
China Pharma Q1 EPS ($0.04), Revenue $3.6M, No Estimates 05/17/2016
China Pharma Holdings Reports FY15 EPS $(0.35) vs $(0.91) in FY14, Sales $20.4M 03/31/2016
Alibaba Health Suffers Scandal Over Improper Drug Fees Alibaba Health Suffers Scandal Over Improper Drug Fees – China Money Network - China Money Network 02/05/2016
China Pharma Holdings Q3 EPS $0.10, Revenue $4.8M, No Estimates 11/17/2015
China Pharma Holdings Reports Q2 Loss $0.09, Sales $5.67M, no estimate 08/14/2015
China Pharma Q1 EPS -$0.18, No Est 05/12/2015
China Pharma's (CPHI) CEO Zhilin Li on Q4 2014 Results - Earnings Call Transcript 03/31/2015
China Pharma Holdings, Inc. Reports Q3 EPS of $(0.15), Down 200% YOY 11/14/2014
China Pharma Holdings Reports Q2 EPS of $(0.20), Down 233% YOY; Revenue of $6.10M, Down 75% YOY 08/15/2014
China Pharma Holdings Reports Q1 EPS of $(0.05), Down 133% YOY; Revenue of $7.11M Which May Not Compare $26.78M Est 05/15/2014
What's the Best Chinese Pharma or Biotech Stock? 01/16/2013
And Nobody Saw 'Em Coming: CPHI, APPY, and NEON Sliced and Diced 12/26/2012
Top Narrow Based Indexes For November 26, 2012 11/26/2012
Top 4 Small-Cap Stocks In The Drug Manufacturers-Major Industry With The Highest Profit Margin 05/23/2012
Top 4 Small-Cap Stocks In The Drug Manufacturers-Major Industry With The Highest Revenue 03/02/2012
Earnings Scheduled For November 11 11/11/2011
Rodman & Renshaw Terminates Coverage of China Pharma Holdings 07/26/2011
China Pharma Holdings States It Knows of No Events That Could Have Caused Unusual Market Activity 06/16/2011
China Pharma Reports FY10 EPS of $0.54 03/03/2011
10 Pharma Stocks With 100% Buy Ratings 02/03/2011
China Pharma Reports In-Line Q3 Earnings 11/11/2010
7 More Stocks Hitting 52-Week Lows 09/16/2010
Small-Cap China Pharma Stock Could Double 03/31/2010
Chinese Pharma Stocks Shine 03/25/2010

Unlock

CPHI Ratings Summary

CPHI Quant Ranking